NIFTY50, SENSEX today: Crude oil update, Asian market cues, key things to know before markets open on September 28

The Indian equity benchmarks are set to open lower on Monday, September 28, as indicated by NIFTY futures traded at Gift City in Gandhinagar. GIFT NIFTY futures dropped 77 points to 23,110 amid weak cues from Asian markets.

The benchmark NIFTY50 and SENSEX both ended lower for the seventh consecutive week as of the market close on Friday with investors remaining cautious amid foreign investor outflows, elevated oil prices and a sharp spike in US Treasury yields.

NSE data showed that the NIFTY50 index lost 0.9% or 205.90 points to close at 23,140.50 in the week ended Friday, September 25, while the BSE SENSEX index declined 0.5% or 399.22 points to end at 73,895.74 this week.

Along with the rebounding crude oil prices and US Treasuries hitting multi-year highs, the sentiment was further dented by a defensive trade play and proposals from the government, which in turn triggered a massive selloff in the market.

Asian markets

Most of the Asian markets were trading lower tracking rise in 10-year US bond yields and surging crude prices.

Japan's Nikkei slipped 0.02%, China's Shanghai Composite declined 1.1% and South Korea's KOSPI index tumbled 2%.

Wall Street update

Dow Jones Industrial Average rose 0.93%, S&P 500 index declined 0.51% and tech heavy Nasdaq advanced 0.5%.

Crude oil update

Brent crude futures rose over 1% to $105.64 per barrel on Monday after US President Donald Trump rejected a peace deal from Iran to resolve their conflict and reopen the Strait of Hormuz, keeping tensions in the Middle East elevated.

US bond yields

The 10-year US bond yield surged to its highest level in nearly 20 years to 5.2%.

Rising bond yields in US makes American bond markets more attractive leading to a flight of money to the safety of bonds from emerging market equities like India, analysts noted.

When US Treasury yields rise investors can get a higher low-risk return in US government securities which makes Indian assets relatively less attractive, analysts added.

FII/DII activity

Foreign institutional investors (FIIs) sold shares worth ₹3,693.93 crore on Friday while domestic institutional investors bought stocks worth ₹2,838 crore, as per NSE data.

FIIs have so far this month sold shares worth ₹17,131 crore taking the total quantum of selling to ₹2,41,572 crore for 2026, data from NSDL showed.

Stocks to watch

The strategic partnership is designed to simplify the creation and extinguishment of electronic gold receipts (EGR) and promote their trading on the exchange, NSE said in a statement on Saturday.

Under the arrangement, Augmont will provide technical and on-ground support for the development of the EGR product, drawing on its experience across the gold value chain.\

The diversified conglomerate, which entered the fresh dairy business in 2018 with the launch of Aashirvaad milk in Bihar and later expanded to West Bengal and Jharkhand, has emerged as the second-largest dairy player in Bihar with a lineup ranging from fresh milk to curd, paneer, lassi and Mishti Doi.

The proposal, contained in the notice for the company's forthcoming general meeting, seeks approval for distribution of a sum not exceeding 1% per annum of profits calculated under Section 198 of the Companies Act, 2013, among the directors in such amounts and proportions as may be decided by the board from time to time.

Shareholders had last approved the commission arrangement at the annual general meeting held on September 28, 2021, for FY22 to FY26. The earlier approvals for similar payments were granted in 2007, 2011 and 2016, according to the shareholder notice.

In an interview with PTI, Gollagunta said the company has already taken three price increases this year -- in January, April and July, with the July increase being about 2.7% on sports utility vehicles (SUVs).

In an interview with PTI, Chandra said the passenger vehicle business, which became a standalone entity following the demerger effective October 1 last year, has grown nearly 40% over the past year and is exiting September with electric vehicles accounting for more than 25% of its total sales.

Following the acquisition, Sunshine Healthcare Ltd (SHL) has become a step-down subsidiary of Dr Lal PathLabs, the company said in a regulatory filing.

The inspection by the US Food and Drug Administration (USFDA) was conducted from September 22 to September 25, 2026, the company said in a regulatory filing.